XONVEA 10 mg/10 mg, gastro-resistant tablet 40 tablets
Active ingredients: Pyridoxine hydrochloride, Doxylamine succinate
Commercialized according to BDPMDispensing in France: Prescription only
Gastro-resistant tablet40 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- XONVEA 10 mg/10 mg, comprimé gastro-résistant
- Pharmaceutical form
- comprimé gastro-résistant(e)
- Route of administration
- orale
- Presentation description
- plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 40 comprimé(s)
- Marketing authorisation holder
- EXELTIS SANTE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Mar 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63374431CIP73023822CIP133400930238226Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| HYDROGÉNOSUCCINATE DE DOXYLAMINEcomprimé | 10 mg · un comprimé | SA |
| CHLORHYDRATE DE PYRIDOXINEcomprimé | 10 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.